FDZ Gesundheit announces extended data model covering ambulatory specialist care

Germany’s Forschungsdatenzentrum Gesundheit (FDZ) has announced an extension to its data model that now incorporates ambulatory specialist care, meaningfully broadening the scope of claims-based research available through the platform. Previously, analyses were largely anchored in inpatient and primary care data, leaving a notable gap in the outpatient specialist pathway — a critical juncture for many chronic and oncology indications. This development brings FDZ closer to enabling genuine end-to-end patient journey analyses within the statutory health insurance framework. The extension aligns with growing regulatory and HTA expectations for richer, more contextually complete real-world evidence in market access submissions. For pharma and MedTech teams pursuing RWE strategies in Germany, this expanded data architecture warrants prompt re-evaluation of feasibility assessments for studies previously considered impractical or insufficiently powered using FDZ infrastructure.